Francesco Serino, MD, is a Staff Physician in the Heart & Vascular Institute at Cleveland Clinic Abu Dhabi.
Prior to joining Cleveland Clinic Abu Dhabi, Dr. Serino worked at the Istituto Dermopatico Immacolata IRCCS in Rome, Italy, where he held multiple roles and established the Endovascular Program, which he later directed. The program pioneered several procedures, including aortic endograft surgery, hybrid endo bypass surgery and gene therapy. The center also performed the first AneuRX graft implant in the country and launched the first clinical research program on therapeutic angiogenesis. He also set up one of the most active centers on diabetic foot revascularization and limb salvage, performing innovative techniques such as laser endarterectomy, absorbable stent technology and crioplasty.
While working at Istituto Dermopatico Immacolata IRCCS, Dr. Serino performed more than 3,000 vascular interventions, served as site Principal Investigator of 12 clinical research projects, completed 212 publications, and presented as faculty in 128 national or international medical meetings.
Prior to his time at Istituo Dermopatico Immacolata IRCCS, Dr. Serino held roles as an Assistant Professor and Associate Consultant at Catholic University Hospital in Rome. It was here that Dr. Serino started one of the first diabetic foot surgery programs in Italy and the first endovascular program in Rome.
Dr. Serino graduated with honors from the Catholic University School of Medicine in Rome, Italy and completed his residency in General Surgery at the Università La Sapienza.